BIO-GATE AG (BIG1.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:BIG1 - DE000BGAG981 - Common Stock
BIG1.DE Key Statistics, Chart & Performance
The current stock price of BIG1.DE is 0.955 EUR. In the past month the price increased by 13.69%. In the past year, price increased by 9.77%.
BIG1.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1COV.DE | COVESTRO AG | N/A | 11.17B | ||
| SY1.DE | SYMRISE AG | 19.68 | 9.99B | ||
| AKZA.AS | AKZO NOBEL N.V. | 15.4 | 9.59B | ||
| AKU1.DE | AKZO NOBEL N.V. | 15.14 | 9.43B | ||
| SYENS.BR | SYENSQO SA | 21.62 | 7.30B | ||
| EVK.DE | EVONIK INDUSTRIES AG | 9.76 | 6.18B | ||
| AKE.PA | ARKEMA | 10.18 | 3.99B | ||
| UMI.BR | UMICORE | 13.41 | 3.73B | ||
| NVJP.DE | UMICORE | 13.39 | 3.73B | ||
| WCH.DE | WACKER CHEMIE AG | 154.19 | 3.46B | ||
| RBT.PA | ROBERTET SA | 18.76 | 1.91B | ||
| ACT.DE | ALZCHEM GROUP AG | 21.11 | 1.31B |
Related stock screener links
About BIG1.DE
Company Profile
Bio-Gate AG engages in the development and production of technologies and solutions for health and hygiene, primarily used in orthopedics, traumatology, and vascular surgery. The company is headquartered in Nuremberg, Bayern and currently employs 46 full-time employees. The company went IPO on 2006-04-05. The firm employs silver technology to endow materials and products with antimicrobial properties, and specializes in plasmacoating, spray, additives and textile solutions, among others. The company produces medical technology products, as well as technologies to refine cosmetics, consumer goods and industrial products. Its products are applied in the area of implants, skin care, cosmetics, orthopedics, industrial applications, consumer goods, would care, textiles and dental products. The firm incorporates silver particles into cosmetics, paints, veneers or plastics, or involves coating of final products, such as implants or wound dressings, with a silver-containing functional layer.
Company Info
BIO-GATE AG
Neumeyerstrasse 28-34
Nuremberg BAYERN DE
Employees: 46
Phone: 49911477523100
BIO-GATE AG / BIG1.DE FAQ
What does BIG1 do?
Bio-Gate AG engages in the development and production of technologies and solutions for health and hygiene, primarily used in orthopedics, traumatology, and vascular surgery. The company is headquartered in Nuremberg, Bayern and currently employs 46 full-time employees. The company went IPO on 2006-04-05. The firm employs silver technology to endow materials and products with antimicrobial properties, and specializes in plasmacoating, spray, additives and textile solutions, among others. The company produces medical technology products, as well as technologies to refine cosmetics, consumer goods and industrial products. Its products are applied in the area of implants, skin care, cosmetics, orthopedics, industrial applications, consumer goods, would care, textiles and dental products. The firm incorporates silver particles into cosmetics, paints, veneers or plastics, or involves coating of final products, such as implants or wound dressings, with a silver-containing functional layer.
What is the stock price of BIO-GATE AG today?
The current stock price of BIG1.DE is 0.955 EUR. The price increased by 5.52% in the last trading session.
Does BIO-GATE AG pay dividends?
BIG1.DE does not pay a dividend.
What is the ChartMill rating of BIO-GATE AG stock?
BIG1.DE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What do analysts say about BIO-GATE AG (BIG1.DE) stock?
7 analysts have analysed BIG1.DE and the average price target is 3.06 EUR. This implies a price increase of 220.42% is expected in the next year compared to the current price of 0.955.
What is the ownership structure of BIO-GATE AG (BIG1.DE)?
You can find the ownership structure of BIO-GATE AG (BIG1.DE) on the Ownership tab.
BIG1.DE Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to BIG1.DE. When comparing the yearly performance of all stocks, BIG1.DE turns out to be only a medium performer in the overall market: it outperformed 52.15% of all stocks.
BIG1.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BIG1.DE. While BIG1.DE seems to be doing ok healthwise, there are quite some concerns on its profitability.
BIG1.DE Financial Highlights
Over the last trailing twelve months BIG1.DE reported a non-GAAP Earnings per Share(EPS) of -0.15. The EPS increased by 31.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -32.97% | ||
| ROE | -151.1% | ||
| Debt/Equity | 0 |
BIG1.DE Forecast & Estimates
7 analysts have analysed BIG1.DE and the average price target is 3.06 EUR. This implies a price increase of 220.42% is expected in the next year compared to the current price of 0.955.
For the next year, analysts expect an EPS growth of 39.39% and a revenue growth 13.3% for BIG1.DE